Acțiunea: A 1.1.4 Atragerea de personal cu competențe avansate din străinătate pentru consolidarea capacității de CD
Denumire Proiect: Stabilirea Profilului Molecular al Neoplasmelor Mieloproliferative și al Leucemiei Acute Mieloide pentru Designul unor Strategii de Diagnostic Precoce, Prognostic și Tratament (MYELOAL – EDIAPROT)
ID / Cod My SMIS: P 37_798/106774
Nr. Contract: 149/26.10.2016



Proposals for new projects or integrations into existing networks:

Proiect COST (European Cooperation in Science and Technology): P2X receptors as a therapeutic opportunity (contracted)
Acronym: PRESTO
Proposal ID C21130

Coordinator: Elena Adinolfi, Department of Medical Sciences, Ferrara, Italia
(COST receives EU funding under the various Research and Innovation Framework Programmes, such as Horizon 2020 and Horizon Europe – )

Scientific publications:

International Review of Cell and Molecular Biology, vol 366, p 41-81, 2022, IF 6,813: Targets in MPNs and potential therapeutics. Gabriel Levy, Cristina Mambet, Christian Pecquet, Sarah Bailly, Violaine Havelange, Carmen C. Diaconu, Stefan N. Constantinescu

Biomedicines: 2022 Feb 18;10(2):481. doi: 10.3390/biomedicines10020481. PMID: 35203690; PMCID: PMC8962344; IF 6,081; Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery; Autori: Stoica SI, Bleotu C, Ciobanu V, Ionescu AM, Albadi I, Onose G, Munteanu C.

Int J Mol Sci, 2022., 23, 12415,;  IF 6,208. Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer. Autori: Necula L, Matei L, Dragu D, Pitica I, Neagu A, Bleotu C, Diaconu CC, Chivu-Economescu M.